A cutting-edge genetic test can rapidly detect and identify almost any kind of disease-causing microorganism in the human ...

Joe McKay tried everything medicine had to offer for the blinding headaches that began in the months after 9/11, when the ...

The agency’s ability to hire and retain skilled employees may be in jeopardy given Trump ally Robert F. Kennedy Jr.’s ...

BioNTech said that it is acquiring the Chinese drugmaker Biotheus for $800 million to bolster its cancer strategy. The two ...

The reelection of former President Donald Trump, coupled with Republicans gaining the Senate majority and poised to gain the House majority, ...

Healthcare & Pharmaceuticalscategory Teen in critical condition with Canada's first presumptive human case of bird flu November 12, 2024 Healthcare & Pharmaceuticalscategory US FDA declines full ...

For the second time in less than a year, the FDA has issued a complete response ... Survodutide advances for MASH In more positive news for Zealand, its Boehringer Ingelheim-partnered dual ...

A study of Gila monster venom helped start the revolution in weight-loss drugs. But scientists think that’s just the ...

Novartis has claimed accelerated approval from the FDA for a second indication for Fabhalta – IgA nephropathy (IgAN) – as it charts a course to blockbuster sales for the drug. The US regulator ...

A trader works at the New York Stock Exchange (NYSE), after Republican presidential nominee Donald Trump won the election, in New York City, U.S., November 6, 2024. REUTERS/Andrew Kelly/File Photo ...

After a brutal year of layoffs in 2023, companies this year have continued to cut jobs across tech ... in the fourth quarter of 2024. The news came shortly after Beyond Inc. and Kirkland announced ...